Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

Olivier Rascol, E. Melamed, Wolfgang H. Oertel, +3

The Lancet

Adjunct TherapyParkinson DiseaseNeuropharmacologyRasagiline Given OnceClinical Neuroscience +6

Quantitative measurement of pain sensation in patients with Parkinson disease

Ruth Djaldetti, Alexander L. Shifrin, Zeev Rogowski, +3

Neurology

Reduction in regional cerebral blood flow during normal aging in man.

E. Melamed, S. Lavy, Shlomo Bentin, +2

Stroke

AgingCerebrovascular DiseaseBrain CirculationMean BrainCerebral Vascular Regulation +14

Stimulation of nigrostriatal dopamine neurones by nicotine

W. Lichtensteiger, Franz Hefti, D. Felix, +3

Neuropharmacology

NeurophysiologyNicotineNeuropharmacologyNeuroscienceNeurology +6

Increased plasma endothelin-1 in acute ischemic stroke.

I. Ziv, Gideon Fleminger, Ruth Djaldetti, +3

Stroke

Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa

J. M. Rabey, I Sági, M. Huberman, +7

Clinical Neuropharmacology

Translational MedicineNew Mao-b InhibitorAdjunctive TherapyMedicineParkinson Disease +13

The site of dopamine formation in rat striatum after L-dopa administration.

Franz Hefti, E. Melamed, R. J. Wurtman

Journal of Pharmacology and Experimental Therapeutics

Effect of chronic atrial fibrillation on regional cerebral blood flow.

S. Lavy, S Stern, E. Melamed, +3

Stroke

Ischemic StrokeCardiovascular DiseaseNeurophysiologyMedicineCerebrovascular Disease +10

Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents

Mark A. Hellmann, Hana Panet, Yael Barhum, +2

Neuroscience Letters

Regenerative MedicineDevelopmental BiologyMarrow TransplantationMedicineAdult Stem Cell +8

Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease.

Gali Friedberg, J Zoldan, Abraham Weizman, +1

PubMed

NeuropsychologyPsychiatric EvaluationParkinsonian PsychosisNeuropsychiatrySocial Sciences +15